Furthermore, ATP-binding cassette transporters that govern the elimination of chemotherapeutic drugs in cancer cells are regulated by NRF2 as well, conferring the chemoresistance phenotype on tumor (Singh et al., 2010). This evidence concerns the gene NFE2L2 and neoplasm.